These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27000212)

  • 1. Neurotrophic factors in Parkinson's disease are regulated by exercise: Evidence-based practice.
    da Silva PG; Domingues DD; de Carvalho LA; Allodi S; Correa CL
    J Neurol Sci; 2016 Apr; 363():5-15. PubMed ID: 27000212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of neurotrophic factors are unchanged in patients with Parkinson's disease.
    Rocha NP; Ferreira JPS; Scalzo PL; Barbosa IG; Souza MS; Christo PP; Reis HJ; Teixeira AL
    Arq Neuropsiquiatr; 2018 May; 76(5):310-315. PubMed ID: 29898077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of voluntary, and forced exercises on neurotrophic factors and cognitive function in animal models of Parkinson's disease.
    Rafie F; Rajizadeh MA; Shahbazi M; Pourranjbar M; Nekouei AH; Sheibani V; Peterson D
    Neuropeptides; 2023 Oct; 101():102357. PubMed ID: 37393777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical training prevents depressive symptoms and a decrease in brain-derived neurotrophic factor in Parkinson's disease.
    Tuon T; Valvassori SS; Dal Pont GC; Paganini CS; Pozzi BG; Luciano TF; Souza PS; Quevedo J; Souza CT; Pinho RA
    Brain Res Bull; 2014 Sep; 108():106-12. PubMed ID: 25264157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate-intensity interval training increases serum brain-derived neurotrophic factor level and decreases inflammation in Parkinson's disease patients.
    Zoladz JA; Majerczak J; Zeligowska E; Mencel J; Jaskolski A; Jaskolska A; Marusiak J
    J Physiol Pharmacol; 2014 Jun; 65(3):441-8. PubMed ID: 24930517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of repetitive transcranial magnetic stimulation in an animal model of Parkinson's disease.
    Lee JY; Kim SH; Ko AR; Lee JS; Yu JH; Seo JH; Cho BP; Cho SR
    Brain Res; 2013 Nov; 1537():290-302. PubMed ID: 23998987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise-induced neuroplasticity in human Parkinson's disease: What is the evidence telling us?
    Hirsch MA; Iyer SS; Sanjak M
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S78-81. PubMed ID: 26439945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical activity and neurotrophic factors as potential drivers of neuroplasticity in Parkinson's Disease: A systematic review and meta-analysis.
    Rotondo R; Proietti S; Perluigi M; Padua E; Stocchi F; Fini M; Stocchi V; Volpe D; De Pandis MF
    Ageing Res Rev; 2023 Dec; 92():102089. PubMed ID: 37844764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of voluntary and forced exercise in protecting against behavioral asymmetry in a juvenile hemiparkinsonian rat model.
    Landers MR; Kinney JW; Allen DN; van Breukelen F
    Behav Brain Res; 2013 Jul; 248():121-8. PubMed ID: 23597837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotrophic Factors in Parkinson's Disease: What Have we Learned from Pre-Clinical and Clinical Studies?
    Ferreira RN; de Miranda AS; Rocha NP; Simoes E Silva AC; Teixeira AL; da Silva Camargos ER
    Curr Med Chem; 2018; 25(31):3682-3702. PubMed ID: 29532753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise exerts neuroprotective effects on Parkinson's disease model of rats.
    Tajiri N; Yasuhara T; Shingo T; Kondo A; Yuan W; Kadota T; Wang F; Baba T; Tayra JT; Morimoto T; Jing M; Kikuchi Y; Kuramoto S; Agari T; Miyoshi Y; Fujino H; Obata F; Takeda I; Furuta T; Date I
    Brain Res; 2010 Jan; 1310():200-7. PubMed ID: 19900418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. It is not about the bike, it is about the pedaling: forced exercise and Parkinson's disease.
    Alberts JL; Linder SM; Penko AL; Lowe MJ; Phillips M
    Exerc Sport Sci Rev; 2011 Oct; 39(4):177-86. PubMed ID: 21799425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.
    Decressac M; Ulusoy A; Mattsson B; Georgievska B; Romero-Ramos M; Kirik D; Björklund A
    Brain; 2011 Aug; 134(Pt 8):2302-11. PubMed ID: 21712347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise and Parkinson's disease.
    Xu X; Fu Z; Le W
    Int Rev Neurobiol; 2019; 147():45-74. PubMed ID: 31607362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of an aquatic exercise program on BDNF levels in Parkinson's disease patients: short-and long-term outcomes.
    da Silva Germanos S; Vieira B; Reichert Vital da Silva I; da Cunha JJ; Nique S; Striebel V; Pochmann D; Rostirola Elsner V
    Funct Neurol; 2019; 34(2):65-70. PubMed ID: 31556385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospects of Neurotrophic Factors for Parkinson's Disease: Comparison of Protein and Gene Therapy.
    Domanskyi A; Saarma M; Airavaara M
    Hum Gene Ther; 2015 Aug; 26(8):550-9. PubMed ID: 26176331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotrophic factor therapy for Parkinson's disease.
    Rangasamy SB; Soderstrom K; Bakay RA; Kordower JH
    Prog Brain Res; 2010; 184():237-64. PubMed ID: 20887879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive rehabilitation increases BDNF serum levels in parkinsonian patients: a randomized study.
    Frazzitta G; Maestri R; Ghilardi MF; Riboldazzi G; Perini M; Bertotti G; Boveri N; Buttini S; Lombino FL; Uccellini D; Turla M; Pezzoli G; Comi C
    Neurorehabil Neural Repair; 2014 Feb; 28(2):163-8. PubMed ID: 24213955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
    Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo gene delivery of glial cell line--derived neurotrophic factor for Parkinson's disease.
    Kordower JH
    Ann Neurol; 2003; 53 Suppl 3():S120-32; discussion S132-4. PubMed ID: 12666104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.